Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Masso

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Anesthesiology|April 26, 2000
Prediction of difficult mask ventilationO Langeron, E Masso, C Huraux, et al.
Transplantation Proceedings|August 16, 2011
Kidney transplantation and waiting list for renal transplantation for human immunodeficiency virus patientsM N Martina, F Cofan, A Suarez, et al.
Journal of Medicinal Chemistry|August 28, 1998
New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors: candidates for clinical developmentG Bold, A Fässler, H G Capraro, et al.
Journal of Medicinal Chemistry|July 6, 2000
New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesisG Bold, K H Altmann, J Frei, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Anesthesiology|April 26, 2000
Prediction of difficult mask ventilationO Langeron, E Masso, C Huraux, et al.
Transplantation Proceedings|August 16, 2011
Kidney transplantation and waiting list for renal transplantation for human immunodeficiency virus patientsM N Martina, F Cofan, A Suarez, et al.
Journal of Medicinal Chemistry|August 28, 1998
New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors: candidates for clinical developmentG Bold, A Fässler, H G Capraro, et al.
Journal of Medicinal Chemistry|July 6, 2000
New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesisG Bold, K H Altmann, J Frei, et al.
Pageof 1